Skip to main content

Table 2 Asthma exacerbations and oral steroid prescriptions among the TZD and non-TZD groups

From: Thiazolidinediones and the risk of asthma exacerbation among patients with diabetes: a cohort study

Event

TZD

Non-TZD

p-value

Patients with an exacerbation* (%)

4.7

5.9

0.03

# of exacerbations (mean/SD)

0.08 (0.41)

0.10 (0.54)

0.06

Patients with a steroid prescription (%)

15 · 1

19.4

<0.01

# of steroid prescriptions (mean/SD)

0.35 (1.32)

0.50 (1.66)

<0.01

  1. *Includes both inpatient and outpatient exacerbations.